Industry sponsorship and research outcome A Lundh, J Lexchin, B Mintzes, JB Schroll, L Bero Cochrane database of systematic reviews, 2017 | 1936 | 2017 |
A consensus-based checklist for reporting of survey studies (CROSS) A Sharma, NT Minh Duc, T Luu Lam Thang, NH Nam, SJ Ng, KS Abbas, ... Journal of general internal medicine 36 (10), 3179-3187, 2021 | 769 | 2021 |
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA B Mintzes, ML Barer, RL Kravitz, K Bassett, J Lexchin, A Kazanjian, ... Cmaj 169 (5), 405-412, 2003 | 426 | 2003 |
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey B Mintzes, ML Barer, RL Kravitz, A Kazanjian, K Bassett, J Lexchin, ... Bmj 324 (7332), 278-279, 2002 | 391 | 2002 |
Direct to consumer advertising is medicalising normal human experienceFor B Mintzes Bmj 324 (7342), 908-911, 2002 | 281 | 2002 |
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs A Cassels, MA Hughes, C Cole, B Mintzes, J Lexchin, JP McCormack Cmaj 168 (9), 1133-1137, 2003 | 263 | 2003 |
The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures L Bero, N Chartres, J Diong, A Fabbri, D Ghersi, J Lam, A Lau, ... Systematic reviews 7, 1-11, 2018 | 210 | 2018 |
Direct-to-consumer advertising of prescription drugs: the evidence says no J Lexchin, B Mintzes Journal of Public Policy & Marketing 21 (2), 194-201, 2002 | 178 | 2002 |
Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States B Mintzes, J Lexchin, JM Sutherland, MD Beaulieu, MS Wilkes, G Durrieu, ... Journal of general internal medicine 28, 1368-1375, 2013 | 156 | 2013 |
Overdiagnosis of bone fragility in the quest to prevent hip fracture TLN Järvinen, K Michaëlsson, J Jokihaara, GS Collins, TL Perry, ... Bmj 350, 2015 | 145 | 2015 |
Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance GE Hanley, B Mintzes BMC Pregnancy and Childbirth 14, 1-12, 2014 | 145 | 2014 |
Industry sponsorship and research outcome: systematic review with meta-analysis A Lundh, J Lexchin, B Mintzes, JB Schroll, L Bero Intensive care medicine 44, 1603-1612, 2018 | 137 | 2018 |
Disease mongering in drug promotion: do governments have a regulatory role? B Mintzes PLoS Medicine 3 (4), e198, 2006 | 135 | 2006 |
Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006) JR Daw, B Mintzes, MR Law, GE Hanley, SG Morgan Clinical therapeutics 34 (1), 239-249. e2, 2012 | 133 | 2012 |
Sex, lies, and pharmaceuticals: how drug companies plan to profit from female sexual dysfunction R Moynihan, B Mintzes Greystone Books, 2010 | 102 | 2010 |
Pathways to independence: towards producing and using trustworthy evidence R Moynihan, L Bero, S Hill, M Johansson, J Lexchin, H Macdonald, ... Bmj 367, 2019 | 101 | 2019 |
Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm? B Mintzes Annual review of public health 33, 259-277, 2012 | 95 | 2012 |
Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults SG Morgan, D Weymann, B Pratt, K Smolina, EJ Gladstone, C Raymond, ... Age and ageing 45 (4), 535-542, 2016 | 89 | 2016 |
Medicines information and the regulation of the promotion of pharmaceuticals T Leonardo Alves, J Lexchin, B Mintzes Science and Engineering Ethics 25 (4), 1167-1192, 2019 | 86 | 2019 |
Trends and determinants of prescription drug use during pregnancy and postpartum in British Columbia, 2002–2011: a population-based cohort study K Smolina, GE Hanley, B Mintzes, TF Oberlander, S Morgan PloS one 10 (5), e0128312, 2015 | 85 | 2015 |